通过双重免疫疗法诱导耐久缓解在感染SHIV的ART抑制

So-Yon Lim1, Jina Lee1, Christa E Osuna1

  • 1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

Science (New York, N.Y.)
|February 29, 2024
PubMed
概括

在停止抗逆转录病毒治疗 (ART) 后,N-803和广泛中和抗体 (bNAbs) 有助于控制猿人免疫缺陷病毒 (SHIV). 这表明持续的艾滋病毒缓解不需要完全根除病毒.